FEZ1/LZTS1 is down-regulated in high-grade bladder cancer, and its restoration suppresses tumorigenicity in transitional cell carcinoma cells.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  American Journal of Pathology

• Publication date

  2002-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0002-9440(10)62561-8PMID 11943719PMCID PMC1867220
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fez1/lzts1 alterations in gastric carcinoma.

  2001influential reference
• FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis

  2001cited by this paper
• Functional identification of LZTS1 as a candidate prostate tumor suppressor gene on human chromosome 8p22

  2001cited by this paper
• Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells.

  2001cited by this paper
• Checking out the G(2)/M transition.

  2001cited by this paper
• Cancer Statistics, 2001

  2001cited by this paper
• Loss of heterozygosity at chromosome segments 8p22 and 8p11.2-21.1 in transitional-cell carcinoma of the urinary bladder.

  2000cited by this paper
• The genetics of transitional cell carcinoma: progress and potential clinical application

  1999cited by this paper
• Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation

  1999cited by this paper
• Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.

  1999cited by this paper
• The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors.

  1999cited by this paper
• TNM Classification of Malignant Tumors

  1998cited by this paper
• Human bladder cancers and normal bladder mucosa present the same hot spot of heterozygous chromosome‐9 deletion

  1998cited by this paper
• Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer

  1998cited by this paper
• The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee.

  1998cited by this paper
• Chromosomal aberrations associated with invasion in papillary superficial bladder cancer

  1998cited by this paper
• Flow cytometric methods of analyzing apoptotic cells.

  1998cited by this paper
• The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder

  1998cited by this paper
• Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization.

  1997cited by this paper
• Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer.

  1997cited by this paper
• Functional evidence for a colorectal cancer tumor suppressor gene at chromosome 8p22-23 by monochromosome transfer.

  1996cited by this paper
• Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer

  1996cited by this paper
• Phosphorylation of elongation factor-1 (EF-1) by cdc2 kinase.

  1995cited by this paper
• Two molecular pathways to transitional cell carcinoma of the bladder.

  1994cited by this paper
• Cancer statistics

  1989cited by this paper

• Identification of cell adhesion-related subtypes and construction of risk model to predict breast cancer prognostic and immunological properties

  2025cites this paper
• Increased LZTS1 expression is associated with a good response to paclitaxel-based chemotherapy in breast cancer.

  2022cites this paper
• Comprehensive analysis of prognosis‐related methylated sites in breast carcinoma

  2020cites this paper
• The Actin Binding Protein Plastin-3 Is Involved in the Pathogenesis of Acute Myeloid Leukemia

  2019cites this paper
• Drug Targeting and Biomarkers in Head and Neck Cancers: Insights from Systems Biology Analyses

  2018cites this paper
• Research progress of oncogene and tumor suppressor gene in bladder cancer.

  2015cites this paper
• MicroRNA-135b Regulates Leucine Zipper Tumor Suppressor 1 in Cutaneous Squamous Cell Carcinoma

  2015cites this paper
• The tumor-suppressor gene LZTS1 suppresses colorectal cancer proliferation through inhibition of the AKT-mTOR signaling pathway.

  2015cites this paper
• The tumor-suppressor gene LZTS1 suppresses hepatocellular carcinoma proliferation by impairing PI3K/Akt pathway.

  2015cites this paper
• Loss of Leucine Zipper Putative Tumor Suppressor 1 (LZTS1) Expression Contributes to Lymph Node Metastasis of Breast Invasive Micropapillary Carcinoma

  2015cites this paper
• University of Dundee MicroRNA-135 b Regulates Leucine Zipper Tumor Suppressor 1 in Cutaneous Squamous Cell Carcinoma

  2015cites this paper
• Regulatory network of differentially expressed genes in metastatic osteosarcoma.

  2015cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology

  2014cites this paper
• Biomarkers in bladder cancer: translational and clinical implications.

  2014cites this paper
• Targeting CDC25C, PLK1 and CHEK1 to overcome Docetaxel resistance induced by loss of LZTS1 in prostate cancer

  2014cites this paper
• Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.

  2014cites this paper
• MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1

  2013cites this paper
• LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer

  2013cites this paper
• The expression profile of the tumor suppressor gene Lzts1 suggests a role in neuronal development

  2012influential citation
• LZTS1 (leucine zipper, putative tumor suppressor 1)

  2012cites this paper
• Tissue‐based Biomarkers

  2012cites this paper
• Down-regulation of leucine zipper putative tumor suppressor 1 is associated with poor prognosis, increased cell motility and invasion, and epithelial-to-mesenchymal transition characteristics in human breast carcinoma.

  2011cites this paper
• Etablissement d'un nouveau modèle pérclinique de cancer de la prostate et identification de biomarqueurs de résistance au docetaxel

  2011cites this paper
• RETRACTED: Mitostatin Is Down-Regulated in Human Prostate Cancer and Suppresses the Invasive Phenotype of Prostate Cancer Cells

  2011cites this paper
• Human Embryonic Mesodermal Progenitors Highly Resemble Human Mesenchymal Stem Cells and Display High Potential for Tissue Engineering Applications

  2010cites this paper
• The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network

  2010cites this paper
• FEZ1/LZTS1 protein expression in ovarian cancer

  2010influential citation
• High‐resolution analysis of genomic alteration on chromosome arm 8p in urothelial carcinoma

  2010cites this paper
• Molecular Profile of Esophageal Cancer Patients in North East Region of India

  2009cites this paper
• Progressive increase of genetic alteration in urinary bladder cancer by combined allelotyping analysis and comparative genomic hybridization.

  2009cites this paper
• Reduction of TIP30 correlates with poor prognosis of gastric cancer patients and its restoration drastically inhibits tumor growth and metastasis

  2009cites this paper
• Down-regulation of tumor suppressor gene FEZ1/LZTS1 in breast carcinoma involves promoter methylation and associates with metastasis

  2009cites this paper
• Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis.

  2008cites this paper
• Predictive biomarkers and signatures in urinary bladder cancer.

  2008cites this paper
• MITOSTATIN, a Putative Tumor Suppressor on Chromosome 12q24.1, is Down-regulated in Human Bladder and Breast Cancer

  2008cites this paper
• Molecular cytogenetic characterization and diagnostics of bladder cancer.

  2007cites this paper
• Fez1/Lzts1 absence impairs Cdk1/Cdc25C interaction during mitosis and predisposes mice to cancer development.

  2007cites this paper
• Take Your "M" Time

  2007cites this paper
• CIAPIN1 inhibits gastric cancer cell proliferation and cell cycle progression by downregulating cyclyinD1 and upregulating p27

  2007cites this paper
• Chromosomal deletions in bladder cancer: shutting down pathways.

  2007cites this paper
• Transcriptional profiles in melanocytes from clinically unaffected skin distinguish the neoplastic growth pattern in patients with melanoma

  2007cites this paper
• Fez1/Lzts1 a new mitotic regulator implicated in cancer development

  2007influential citation
• Targeted therapies in the management of metastatic bladder cancer

  2007cites this paper
• Mutation and expression analysis of LZTS1 in ovarian cancer.

  2006cites this paper
• Molecular genetics of bladder cancer: targets for diagnosis and therapy.

  2006cites this paper
• Ciblage du PAX2 pour l'induction de l'immunité à la tumeur à médiation DEFB1 et le traitement contre le cancer

  2006cites this paper
• Reduced FEZ1/LZTS1 expression and outcome prediction in lung cancer.

  2005influential citation
• Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.

  2005cites this paper
• Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer

  2004cites this paper
• Inactivation of the FHIT Gene Favors Bladder Cancer Development

  2004cites this paper
• Analysis of the transcription regulator, CNOT7, as a candidate chromosome 8 tumor suppressor gene in colorectal cancer

  2003cites this paper